Free tool
FAERS Monitor: An-Sulfur Colloid
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017858 or its brand name (An-Sulfur Colloid, Technetium Tc-99m Sulfur Colloid Kit). Reports on generic versions are filed under their own applications.
Reports
6
Serious
3
50% of reports
Hospitalization
3
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea2
- sepsis2
- vomiting2
- blister1
- convulsion1
- flushing1
- hypersensitivity1
- injection site irritation1
- nosocomial infection1
- seizure1
- sensation of foreign body1
- sense of oppression1
- skin graft1
- skin necrosis1
- sneezing1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 1 |
| 2009 | 2 |
| 2014 | 2 |
| 2019 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,153 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| skin graft | 1 | 3781.3 | 631.1 | 943 |
| sense of oppression | 1 | 2983.9 | 498.1 | 744 |
| nosocomial infection | 1 | 1592.1 | 265.9 | 397 |
| skin necrosis | 1 | 675.9 | 112.9 | 168 |
| sensation of foreign body | 1 | 416.0 | 69.5 | 103 |
| injection site irritation | 1 | 275.5 | 46.0 | 68 |
| sneezing | 1 | 156.3 | 26.1 | 38 |
| sepsis | 2 | 62.9 | 20.3 | 68 |
| blister | 1 | 62.4 | 10.4 | 15 |
| convulsion | 1 | 61.3 | 10.2 | 14 |
| flushing | 1 | 34.5 | 5.8 | 8 |
| seizure | 1 | 30.3 | 5.1 | 7 |
| hypersensitivity | 1 | 18.9 | 3.2 | 4 |
| vomiting | 2 | 14.9 | 4.8 | 14 |
| nausea | 2 | 8.9 | 2.9 | 7 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.